Releases
Found 41417 articles
Corvex Reports $22 Million in Contracted AI Compute Revenue
Corvex, Inc. disclosed $3.8 million in revenue for the second quarter of 2026, marking its first full reporting period following the company’s pivot to AI cloud infrastructure. While the firm posted a net loss of $12.8 million, leadership pointed to a $22 million annualized recurring revenue figure as evidence of growth.
BorgWarner Sets Pricing for Multi-Series Debt Tender Offers
BorgWarner Inc. has finalized the pricing for its cash tender offers aimed at repurchasing various series of outstanding senior notes. The move, intended to optimize the company’s capital structure and long-term earnings, covers debt instruments maturing between 2027 and 2045 with varying tender considerations.
Citius Oncology Reports Rising Institutional Demand for LYMPHIR
Citius Oncology is gaining commercial traction as institutional adoption of its lymphoma treatment, LYMPHIR, accelerates. The company reported that 44 medical centers have now prescribed the drug, with vial orders jumping 31% sequentially in the third fiscal quarter of 2026, signaling a shift toward wider market penetration.
Citius Pharma reports revenue growth as LYMPHIR launch gains traction
Citius Pharmaceuticals reported $7.1 million in revenue for the first nine months of fiscal 2026, driven by the commercial rollout of its targeted immunotherapy, LYMPHIR. The company, which maintains $17 million in cash reserves, is now leveraging an expanded nationwide sales team to secure deeper penetration across academic and community oncology centers.
Ondo Stocks Hits $1 Billion Milestone as Tokenized Assets Surge
Ondo Finance has surpassed $1 billion in total value locked for its tokenized equities platform, Ondo Stocks, less than a year after its launch. The milestone highlights a broader acceleration in the ecosystem, which has now reached 200,645 holders, marking a 20% increase in participation over the last 30 days.
A1R Water Goes Public on Nasdaq to Scale Atmospheric Hydration
A1R water, a startup that extracts drinking water from atmospheric humidity, finalized its business combination with Inflection Point Acquisition Corp. III on August 14. The move, backed by a $96 million PIPE, shifts the company to the Nasdaq exchange where it will trade under the ticker symbol WATR beginning August 17.
FiEE Reports $2.5 Million Profit Following Strategic Pivot
Osaka-based technology firm FiEE, Inc. has posted a net income of $2.5 million for the first half of 2026, marking a sharp reversal from the $1.0 million loss recorded during the same period last year as the company shifts its focus from legacy hardware toward AI-driven SaaS solutions.
CleanCore Solutions Rebrands as Zone Frontier to Target AI Infrastructure
CleanCore Solutions, the Houston-based company currently trading under the ticker ZONE on the NYSE American, will officially change its corporate name to Zone Frontier Inc. on August 31, 2026. This shift marks the firm’s attempt to pivot away from its legacy operations toward the growing artificial intelligence data center market.
Pennsylvania American Water Implements Rate Hikes for Infrastructure
Pennsylvania American Water is rolling out new rate structures this week to fund a $1.2 billion modernization effort. The utility, which provides service to 2.5 million residents, is simultaneously expanding its H2O Help to Others program to assist households struggling with the increased monthly costs.
Realty Income Closes $1 Billion Convertible Notes Offering
San Diego-based Realty Income Corporation has finalized a $1 billion private offering of 3.750% convertible senior notes due in 2031. The transaction includes the full exercise of a $125 million option by initial purchasers, providing the firm with roughly $981.9 million in net proceeds to bolster its capital structure.
Cohen & Steers Realigns Global and International Realty Indexes
Investment manager Cohen & Steers will overhaul the composition of three major real estate equity indexes effective August 21, 2026. The adjustments affect the Global Realty Majors, International Realty Majors, and the firm's namesake Realty Majors portfolios, signaling a shift in the underlying securities tracked by the Chicago Mercantile Exchange.
Invesco Mortgage Capital Declares Dividend Amid Portfolio Update
Invesco Mortgage Capital Inc. has declared a cash dividend of $0.12 per share for August 2026, payable on September 15 to stockholders of record as of August 25. The announcement arrives alongside preliminary financial disclosures detailing a total investment portfolio of $8.1 billion as of the end of July.
FuelRod Supplies Portable Power Kits to FedEx St. Jude Championship
Professional golfers competing in the 2026 FedEx St. Jude Championship at TPC Southwind are receiving Wireless MAX10 portable power kits as part of this year's player gift package. The selection highlights the intersection of the PGA TOUR lifestyle and the demand for reliable, mobile energy solutions during constant travel.
Ziegler Secures $66 Million for BHI Senior Living Affiliates
Investment bank Ziegler has finalized two major bond transactions totaling $66.4 million for Maple Knoll Communities and Westminster Village North. The capital infusion supports two non-profit senior living affiliates of BHI Senior Living, providing debt refinancing and new capital for infrastructure across their Ohio and Indiana campuses.
Real and RE/MAX Holdings Clear Final Hurdle for Merger
Securityholders at The Real Brokerage and RE/MAX Holdings have overwhelmingly voted to approve a merger, clearing the way for the creation of Real REMAX Group. The deal unites a modern technology-powered brokerage platform with one of the industry's most recognizable global franchise networks.
Mosaic Sets Pricing for $1.4 Billion Debt Buyback
The Mosaic Company has finalized the pricing terms for its cash tender offers to repurchase up to $1.4 billion in outstanding senior notes and debentures. The Tampa-based fertilizer giant established specific consideration values for four distinct series of debt, with the buyback window closing on August 14, 2026.
Kroger Sets September Date for Second Quarter Earnings Call
Investors will turn their attention to Cincinnati on September 11, 2026, as The Kroger Co. prepares to host its second quarter earnings conference call. The session, scheduled for 8:00 a.m. ET, follows the close of the company's fiscal quarter on August 15, marking a critical checkpoint for the retail giant.
Alibaba Faces Securities Fraud Lawsuit Over AI Ties and Military Links
Investors who held Alibaba Group Holding Limited stock between June 26, 2025, and June 24, 2026, face an October 5, 2026, deadline to join a class action lawsuit. The litigation, filed by Hagens Berman, alleges the company misled shareholders regarding its regulatory status and improper access to proprietary AI models.
Cardinal Infrastructure Group Faces Investor Probe After Stock Slump
A 36% single-day stock plunge has triggered a securities investigation into Cardinal Infrastructure Group Inc. Shareholders are now questioning whether the company misled them about operational costs and equipment dependencies during its recent secondary offering, which raised over $318 million just weeks before the firm's financial results collapsed.
Hagens Berman Investigates CVRx Following 59% Stock Plunge
A 59% collapse in CVRx stock has triggered a formal investigation by Hagens Berman, a national litigation firm probing potential securities fraud. The inquiry follows a series of disclosures involving a Department of Justice investigation, significant revenue guidance cuts, and the sudden firing of the company’s Chief Revenue Officer.
Suja Life Faces Shareholder Investigation After 70% Stock Collapse
Shares of Suja Life have plunged more than 70% from their $21.00 IPO price just months after the company went public, prompting the national litigation firm Hagens Berman to launch an investigation into potential federal securities law violations regarding the company's business model stability.
BrainStorm Cell Therapeutics Prepares Phase 3b ALS Trial
BrainStorm Cell Therapeutics is moving to initiate its Phase 3b ENDURANCE study for the ALS therapy NurOwn, following a Special Protocol Assessment agreement with the FDA. The company reported a net loss of $3.9 million for the second quarter of 2026 as it shifts its leadership team to prioritize regulatory strategy.
Paramount-Skydance merger clears global regulatory hurdles
Paramount Skydance Corporation has secured regulatory approval for its acquisition of Warner Bros. Discovery in 68 countries, marking the end of an eight-month global review process. Despite this widespread consensus, the merger remains stalled by a legal challenge from a coalition of 12 U.S. state attorneys general.
Investors Face October Deadline in UWM Holdings Securities Lawsuit
Investors who purchased UWM Holdings Corporation securities between March 9 and August 5, 2026, face an October 13 deadline to seek the role of lead plaintiff in a newly filed class action. The lawsuit alleges that the mortgage company misled shareholders regarding its hedging strategies and risk management practices.
Investors Face September Deadline in Cogent Communications Lawsuit
Investors holding Cogent Communications common stock between February 29, 2024, and May 1, 2026, face a September 21, 2026, deadline to serve as lead plaintiff in a class action lawsuit. Hagens Berman Sobol Shapiro LLP filed the action following allegations that the company misled shareholders regarding its optical wavelength backlog.
Preschool Readiness Gaps Reveal Quality Matters More Than Labels
Formal preschool attendance is consistently linked to stronger kindergarten readiness, with some regions reporting performance gaps as wide as 33 percentage points. However, a comprehensive review of longitudinal data suggests that the quality of care and teacher-child interactions are more reliable predictors of long-term academic success than the program's title.
Primoris Faces Investor Lawsuit Over Renewable Energy Project Failures
Investors who purchased Primoris Services Corporation stock between August 5, 2025, and June 22, 2026, face a September 21, 2026, deadline to join a class action lawsuit. Hagens Berman is representing shareholders following a series of disclosures regarding operational failures that severely impacted the company’s financial performance.
Regeneron Faces Securities Lawsuit After Failed Melanoma Trial
A federal securities class action lawsuit has been filed against Regeneron Pharmaceuticals following a failed Phase 3 clinical trial that wiped $11 billion from the company's market capitalization. Investors who purchased common stock between August 1, 2025, and May 15, 2026, must file lead plaintiff applications by September 14, 2026.
EquipmentShare Investors Face Securities Fraud Class Action Deadline
Investors who incurred financial losses from EquipmentShare.com Inc. shares between January 23 and June 23, 2026, face a looming court deadline to participate in a pending securities fraud class action. The law firm Glancy Prongay Wolke & Rotter LLP is currently organizing the effort to seek recovery for affected shareholders.
Photronics Investors Face September Deadline in Securities Lawsuit
Investors holding Photronics stock between December 10, 2025, and May 27, 2026, have until September 4, 2026, to file for lead plaintiff status. The class action lawsuit follows allegations that the company misled shareholders about the stability of its high-end integrated circuit product line and order patterns.